Pharmaceutical

Oxford BioTherapeutics and Roche link on antibody cancer treatments

OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.

Mar 21, 2025 - 06:00
Oxford BioTherapeutics and Roche link on antibody cancer treatments
OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.
Read the original article

Tags:

Previous Article

Pfizer sells 7.3% stake in Haleon for $3.3bn

Next Article

Blood cancers dominate CAR-T pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA grants RMAT to Poseida’s CAR-T cell therapy P-BCMA-ALLO1

FDA grants RMAT to Poseida’s CAR-T cell therapy P-BCMA-...

Sep 18, 2024

Eli Lilly doubles down on Oblique partnership for antibody generation

Eli Lilly doubles down on Oblique partnership for antib...

Aug 25, 2024

Opinion: Why involuntary treatment for addiction is a dangerous idea

Opinion: Why involuntary treatment for addiction is a d...

Apr 25, 2023